NIM
AAPG

NEOS Investment Management’s Ascentage Pharma AAPG Stock Holding History

NEOS Investment Management’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,385
Closed -$412K – 670
2025
Q3 		$412K Sell
10,385
-5,110
-33% -$207K ﹤0.01% 592
2025
Q2 		$610K Buy
+15,495
New +$408K 0.01% 525

Other funds holding AAPG

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIA
Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return

NEOS Investment Management's AAPG Position: Q4 2025 in Review

NEOS Investment Management sold out of Ascentage Pharma (AAPG) in Q4 2025, closing a stake of 10,385 shares — an estimated $412K sold.

NEOS Investment Management first reported a position in AAPG in Q2 2025 and held it in 2 quarters. The position peaked at $610K in Q2 2025. 12 funds tracked by Wall St. Rank hold AAPG as of Q4 2025.

  • NEOS Investment Management reported no remaining Ascentage Pharma position as of Q4 2025 after selling out during the quarter.
  • NEOS Investment Management sold 10,385 Ascentage Pharma shares in Q4 2025, an estimated $412K.
  • NEOS Investment Management first reported a position in Ascentage Pharma in Q2 2025 and held it in 2 quarters.
  • NEOS Investment Management's Ascentage Pharma position peaked at $610K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held Ascentage Pharma as of Q4 2025.

Based on NEOS Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.